These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10328573)

  • 1. Disease-modifying antirheumatic drugs.
    Ryan L; Brooks P
    Curr Opin Rheumatol; 1999 May; 11(3):161-6. PubMed ID: 10328573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-modifying antirheumatic drugs.
    Conaghan PG; Lehmann T; Brooks P
    Curr Opin Rheumatol; 1997 May; 9(3):183-90. PubMed ID: 9204252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
    Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
    Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease-modifying antirheumatic drugs. Potential effects in older patients.
    Gardner G; Furst DE
    Drugs Aging; 1995 Dec; 7(6):420-37. PubMed ID: 8601050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs.
    Dale J; Alcorn N; Capell H; Madhok R
    Nat Clin Pract Rheumatol; 2007 Aug; 3(8):450-8; quiz, following 478. PubMed ID: 17664952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid arthritis: limiting the damage.
    Hosie G
    Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2009 Mar; 19(3):395-403. PubMed ID: 19252250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-modifying antirheumatic drugs.
    Li E; Brooks P; Conaghan PG
    Curr Opin Rheumatol; 1998 May; 10(3):159-68. PubMed ID: 9608316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
    Furst DE
    Clin Exp Rheumatol; 1999; 17(1):39-40. PubMed ID: 10084027
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.
    Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1995 May; 7(3):167-73. PubMed ID: 7612407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
    Shiroky JB
    J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 15. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
    N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.
    Nandi P; Kingsley GH; Scott DL
    Curr Opin Rheumatol; 2008 May; 20(3):251-6. PubMed ID: 18388514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
    O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
    J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
    Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
    Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis.
    Nagashima M; Matsuoka T; Saitoh K; Koyama T; Kikuchi O; Yoshino S
    Clin Exp Rheumatol; 2006; 24(3):260-7. PubMed ID: 16870092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.